Australian Regulators Approve Daily Oral GLP-1 Weight-Loss Medication
Australian regulators have approved a daily oral GLP-1 weight-loss drug, with market availability expected by year-end despite ongoing uncertainty regarding…

The Therapeutic Goods Administration has approved the sale of daily oral semaglutide tablets for chronic weight management. The medication is indicated for adults with a body mass index of 30 or higher, or those with a BMI of 27 to 30 presenting with weight-related comorbidities.
Clinical administration requires a 16-week dose escalation protocol, alongside dietary and physical activity interventions. The drug is also approved for reducing the risk of cardiovascular events, including heart attack and stroke.
Regulatory warnings highlight potential risks including gastrointestinal complications, renal failure, acute pancreatitis, and diabetic retinopathy. Animal studies have indicated a potential link to thyroid tumors, and reports exist regarding psychiatric side effects, including depression and suicidal ideation.
Market availability is expected by late 2026. Pricing remains unconfirmed, and the medication is not currently subsidized under Pharmaceutical Benefits Scheme, necessitating private funding for patients.
More stories
- Dietitians advise small swaps for plant-based eating
- TikTok dementia videos mislead in 66.4% of sample, researchers say
- Aberdeen Royal Infirmary faces police inquiry call over 19 deaths
- Bariatric surgery group loses 28.2% after GLP-1 use
- TOFA boosts mouse energy use 18% while preserving muscle
- ICO probes NHS therapy notes accessible to up to 140,000 staff
- Children with higher ultra-processed intake show stronger reward signals
- Avocado-mango diet linked to 6.7% vessel function in prediabetes
Latest news
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Congress tests Black Democrats' growing policy influence
- Baltic responders fight Sparta II fire after drone strike
- Europe faces attribution gap after 16 cyber, physical incidents

